×
About 1,570 results

ALLMedicine™ Mucormycosis Center

Research & Reviews  565 results

Co-infection of intestinal tuberculosis and mucormycosis in a patient with Down syndrom...
https://doi.org/10.1136/bcr-2021-244903
BMJ Case Reports; Pal B, Thirupathaiah K et. al.

Dec 2nd, 2021 - Mucormycosis represents several unusual opportunistic infection caused by saprophytic aseptate fungi. There is a recent rise in cases of mucormycosis due to an increase in diabetic and immunodeficient patients like patients on long-term steroids, ...

Magnetic Resonance Imaging in Coronavirus Disease - 2019 Associated Rhino-Orbital-Cereb...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564981
Current Problems in Diagnostic Radiology; Yadav T, Tiwari S et. al.

Nov 23rd, 2021 - Rhino-orbital-cerebral mucormycosis has emerged as a major opportunistic infection in patients with COVID-19. High clinical suspicion and prompt imaging are crucial for early diagnosis and management. Our study evaluates imaging characteristics of...

Incidence and risk factors for mucormycosis in renal transplant patients.
https://doi.org/10.1136/jim-2021-001933
Journal of Investigative Medicine : the Official Publicat... Downey MR, Taskar V et. al.

Nov 21st, 2021 - Renal transplant patients are at increased risk for mucormycosis. Diabetes, neutropenia, deferoxamine therapy, and immunosuppressive medications have been associated with increased risk of mucormycosis in studies of solid organ transplant recipien...

Mucormycosis as SARS-CoV2 sequelae in kidney transplant recipients: a single-center exp...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600912
International Urology and Nephrology; Meshram HS, Kute VB et. al.

Nov 19th, 2021 - Coronavirus disease (COVID-19) sequelae in the transplant population are scarcely reported. Post-COVID-19 mucormycosis is one of such sequelae, which is a dreadful and rare entity. The purpose of this report was to study the full spectrum of this ...

COVID-19-associated mucormycosis: Evidence-based critical review of an emerging infecti...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8601521
PLoS Neglected Tropical Diseases; Aranjani JM, Manuel A et. al.

Nov 19th, 2021 - Coronavirus Disease 2019 (COVID-19), during the second wave in early 2021, has caused devastating chaos in India. As daily infection rates rise alarmingly, the number of severe cases has increased dramatically. The country has encountered health i...

see more →

Guidelines  3 results

Global guideline for the diagnosis and management of mucormycosis: an initiative of the...
https://doi.org/10.1016/S1473-3099(19)30312-3
The Lancet. Infectious Diseases; Cornely OA, Alastruey-Izquierdo A et. al.

Nov 9th, 2019 - Mucormycosis is a difficult to diagnose rare disease with high morbidity and mortality. Diagnosis is often delayed, and disease tends to progress rapidly. Urgent surgical and medical intervention is lifesaving. Guidance on the complex multidiscipl...

ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormyc...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394968
Haematologica Tissot F, Agrawal S et. al.

Dec 25th, 2016 - The European Conference on Infections in Leukemia (ECIL) provides recommendations for diagnostic strategies and prophylactic, pre-emptive or targeted therapy strategies for various types of infection in patients with hematologic malignancies or he...

ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormyco...
https://doi.org/10.1111/1469-0691.12371
Clinical Microbiology and Infection : the Official Public... Cornely OA, Arikan-Akdagli S et. al.

Feb 1st, 2014 - These European Society for Clinical Microbiology and Infectious Diseases and European Confederation of Medical Mycology Joint Clinical Guidelines focus on the diagnosis and management of mucormycosis. Only a few of the numerous recommendations can...

see more →

Drugs  2 results see all →

Clinicaltrials.gov  5 results

Combined Inhalational With Intravenous Amphotericin B Versus Intravenous Amphotericin B Alone for Pulmonary Mucormycosis
https://clinicaltrials.gov/ct2/show/NCT04502381

Nov 10th, 2021 - Pulmonary mucormycosis is a relatively a rare disease with a high mortality. The angioinvasion associated with mucormycosis prevents efficient drug delivery at the diseased site. Inhaled amphotericin B achieves drug levels in lung tissue and has b...

Prospective Evaluation of a New Molecular Tool for Early Diagnosis of Mucormycosis
https://clinicaltrials.gov/ct2/show/NCT02845934

Mar 11th, 2021 - The patients eligible for this study will already be hospitalized with repeated monitoring of clinical and biological parameters. Participation in the study will result in an additional sampling of blood (estimated volume 6 mL for each sampling) o...

Mucormycosis in ICU
https://clinicaltrials.gov/ct2/show/NCT03387696

Jan 2nd, 2018 - Mucormycosis is an invasive fungal infection affecting patients with various clinical conditions especially patients with heavy immunosuppression or patients with trauma or extensive burns. The incidence of Mucormycosis is currently increasing rea...

Systemic Fungal Infections in ICU Patients
https://clinicaltrials.gov/ct2/show/NCT03292224

Sep 25th, 2017 - Systemic fungal infections are a significant and growing public health problem ,Over the past few years, major advances in healthcare have led to an unwelcome increase in the number of life-threatening infections due to true pathogenic and opportu...

Safety and Efficacy of Iron Reduction by Phlebotomy
https://clinicaltrials.gov/ct2/show/NCT00689182

Jan 31st, 2017 - Background Hematopoietic stem cell transplantation (HSCT) is increasingly used as a treatment for a variety of malignant and non-malignant conditions. With improvements in conditioning regimens and post-transplant care, more HSCT recipients are be...

see more →

News  53 results

Watch for mucormycosis in COVID-19 patients
https://www.mdedge.com/infectiousdisease/article/242052/invasive-fungal-infections/watch-mucormycosis-covid-19-patients

Jun 24th, 2021 - Key clinical point: Mucormycosis cases surged after the appearance of COVID-19, but adjunct surgery in COVID-19 patients with mucormycosis improved clinical outcomes. Major finding: The mortality rate among 99 COVID-19 patients with mucormycosis w.

Yanked COVID Gene Sequences; Britney Wants to Be Freed; Smuggling Remdesivir
https://www.medpagetoday.com/infectiousdisease/covid19/93262

Jun 24th, 2021 - Note that some links may require registration or subscription. COVAX will be focusing less on partnering with rich countries as part of an internal overhaul. (Reuters) Why were early Chinese COVID cases purged from a gene sequencing database? (Wal...

Skip Routine Probiotics for Preemies, AAP Says
https://www.medscape.com/viewarticle/951764

May 25th, 2021 - The American Academy of Pediatrics (AAP) now recommends against the routine administration of probiotics to preterm infants, particularly the most vulnerable (those whose birth weight is <1000 g), for the treatment or prevention of necrotizing ent...

India Faces Antifungal Drug Shortage as Rare Complication Adds to COVID-19 Woes
https://www.medscape.com/viewarticle/951607

May 24th, 2021 - BENGALURU (Reuters) - India said on Friday that it was working to alleviate a shortage of a medicine used to treat a rare fungal disease hitting COVID-19 patients as its healthcare system reels under a massive wave of coronavirus infections. Cases...

India Battles Rash of 'Black Fungus' Cases Hitting COVID-19 Patients
https://www.medscape.com/viewarticle/951518

May 21st, 2021 - BENGALURU(Reuters) - India has ordered tighter surveillance of a rare fungal disease hitting COVID-19 patients, officials said on Thursday, piling pressure on hospitals struggling with the world's highest number of daily infections of the novel co...

see more →